- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Sorafenib is an oral multi-target kinase inhibitor, and standardized medication, clear efficacy evaluation indicators, and implementation of sa...
During the use of sorafenib, special attention should be paid to adverse reactions such as hepatotoxicity, hypertension, hand foot skin reactio...
Sorafenib has clear contraindications for use, especially in severe liver and kidney dysfunction and pregnant populations with significant risk...
Sorafenib is often accompanied by side effects such as fatigue, decreased appetite, and rash during treatment, which affect the quality of life...
Common side effects of cabozantinib include diarrhea, photosensitivity, and fever. Scientific management of these adverse reactions can reduce ...
Due to the characteristics of cardiomyopathy, hepatotoxicity, and hepatic and renal metabolism, some patients are contraindicated or require ex...
When treating BRAF mutant melanoma with cabozantinib, it is important to pay close attention to its potential toxicity to multiple organs such ...
Cobimetinib is an oral small molecule targeted drug that selectively inhibits MEK kinase, blocks MAPK signaling pathway, and thus inhibits tumo...
Jisanda is a pan genotype oral antiviral drug for hepatitis C, with clear standard usage and dosage, fixed treatment course, and minimal impact...
Jisanda is a core drug for the treatment of hepatitis C, but extra caution should be exercised in specific combination therapy or postoperative...
